Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets

PurposeTo develop mapping algorithms that transform Diabetes-39 (D-39) scores onto EQ-5D-5L utility values for each of eight recently published country-specific EQ-5D-5L value sets, and to compare mapping functions across the EQ-5D-5L value sets.MethodsData include 924 individuals with self-reported diabetes from six countries. The D-39 dimensions, age and gender were used as potential predictors for EQ-5D-5L utilities, which were scored using value sets from eight countries (England, Netherland, Spain, Canada, Uruguay, China, Japan and Korea). Ordinary least squares, generalised linear model, beta binomial regression, fractional regression, MM estimation and censored least absolute deviation were used to estimate the mapping algorithms. The optimal algorithm for each country-specific value set was primarily selected based on normalised root mean square error (NRMSE), normalised mean absolute error (NMAE) and adjusted-r2. Cross-validation with fivefold approach was conducted to test the generalizability of each model.ResultsThe fractional regression model with loglog as a link function consistently performed best in all country-specific value sets. For instance, the NRMSE (0.1282) and NMAE (0.0914) were the lowest, while adjusted-r2 was the highest (52.5%) when the English value set was considered. Among D-39 dimensions, the energy and mobility was the only one that was consistently significant for all models.ConclusionsThe D-39 can be mapped onto the EQ-5D-5L utilities with good predictive accuracy. The fractional regression model, which is appropriate for handling bounded outcomes, outperformed other candidate methods in all country-specific value sets. However, the regression coefficients differed reflecting preference heterogeneity across countries.

[1]  J. Powell,et al.  Least absolute deviations estimation for the censored regression model , 1984 .

[2]  Donna Rowen,et al.  Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  Mark Oppe,et al.  Comparison of the underlying constructs of the EQ-5D and Oxford Hip Score: implications for mapping. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  R. M. Yaremko,et al.  Handbook of Research and Quantitative Methods in Psychology: For Students and Professionals , 1986 .

[5]  S. Dixon,et al.  The use of condition specific outcome measures in economic appraisal. , 1995, Health economics.

[6]  N. Devlin,et al.  EQ-5D and the EuroQol Group: Past, Present and Future , 2017, Applied Health Economics and Health Policy.

[7]  Leslie E. Papke,et al.  Econometric Methods for Fractional Response Variables with an Application to 401(K) Plan Participation Rates , 1993 .

[8]  J. Richardson,et al.  Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs) , 2016, PharmacoEconomics.

[9]  Juan Manuel Ramos-Goñi,et al.  An EQ-5D-5L value set based on Uruguayan population preferences , 2016, Quality of Life Research.

[10]  Esmeralda A. Ramalho,et al.  A Generalized Goodness‐of‐Functional Form Test for Binary and Fractional Regression Models , 2014 .

[11]  Y. Susanti,et al.  M ESTIMATION, S ESTIMATION, AND MM ESTIMATION IN ROBUST REGRESSION , 2014 .

[12]  J. Richardson Cross-national comparison of twelve quality of life instruments , 2012 .

[13]  G. Andrews,et al.  Interpreting scores on the Kessler Psychological Distress Scale (K10) , 2001, Australian and New Zealand journal of public health.

[14]  Philip Paolino,et al.  Maximum Likelihood Estimation of Models with Beta-Distributed Dependent Variables , 2001, Political Analysis.

[15]  S. Ferrari,et al.  Beta Regression for Modelling Rates and Proportions , 2004 .

[16]  Takashi Fukuda,et al.  Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[18]  J. Richardson,et al.  Multiattribute Utility Instruments and Their Use , 2014 .

[19]  J. Olsen,et al.  Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 , 2014, PharmacoEconomics.

[20]  T. Kohlmann,et al.  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  A. Lukman,et al.  Robust Regression Diagnostics of Influential Observations in Linear Regression Model , 2015 .

[22]  Michael Smithson,et al.  A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables. , 2006, Psychological methods.

[23]  Joaquim J. S. Ramalho,et al.  A two-part fractional regression model for the financial leverage decisions of micro, small, medium and large firms , 2009 .

[24]  Helen Dakin,et al.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database , 2013, Health and Quality of Life Outcomes.

[25]  J. Earp,et al.  The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. , 1997, Medical care.

[26]  N. Bansback,et al.  A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada , 2015, Medical care.

[27]  José M. R. Murteira,et al.  Alternative Estimating and Testing Empirical Strategies for Fractional Regression Models , 2011 .

[28]  J. MacKinnon,et al.  Several Tests for Model Specication in the Pres-ence of Alternative Hypotheses , 1981 .

[29]  Duane T. Wegener,et al.  Evaluating the use of exploratory factor analysis in psychological research. , 1999 .

[30]  Matthias Hunger,et al.  Analysis of SF-6D index data: is beta regression appropriate? , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[31]  Gang Chen,et al.  Deriving health utilities from the MacNew Heart Disease Quality of Life Questionnaire , 2015, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[32]  Niels H Chavannes,et al.  Mapping the clinical chronic obstructive pulmonary disease questionnaire onto generic preference-based EQ-5D values. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[33]  John Cairns,et al.  In search of a common currency: A comparison of seven EQ‐5D‐5L value sets , 2018, Health economics.

[34]  F. Kianifard Applied Multivariate Data Analysis: Volume II: Categorical and Multivariate Methods , 1994 .

[35]  Lilani Kumaranayake,et al.  Constructing socio-economic status indices: how to use principal components analysis. , 2006, Health policy and planning.

[36]  Angelo Iezzi,et al.  Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39. , 2015, Diabetes research and clinical practice.

[37]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[38]  Nan Luo,et al.  Estimating an EQ-5D-5L Value Set for China. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[39]  Brendan Mulhern,et al.  Valuing health‐related quality of life: An EQ‐5D‐5L value set for England , 2017, Health economics.

[40]  C. Mihalopoulos,et al.  Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures , 2014, British Journal of Psychiatry.

[41]  Nan Luo,et al.  The EQ-5D-5L valuation study in Korea , 2016, Quality of Life Research.

[42]  Mark Oppe,et al.  Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach , 2014, Medical care.

[43]  G Ardine de Wit,et al.  Dutch Tariff for the Five-Level Version of EQ-5D. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[44]  Huiman X Barnhart,et al.  Overall Concordance Correlation Coefficient for Evaluating Agreement Among Multiple Observers , 2002, Biometrics.

[45]  Oliver Rivero-Arias,et al.  Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[46]  V. Yohai HIGH BREAKDOWN-POINT AND HIGH EFFICIENCY ROBUST ESTIMATES FOR REGRESSION , 1987 .

[47]  Aki Tsuchiya,et al.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.

[48]  Mark Oppe,et al.  Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement. , 2015, Journal of medical economics.

[49]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[50]  Julie Ratcliffe,et al.  Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[51]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[52]  M. Versteegh,et al.  Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.